China Covid update: 180,000 people in Guangdong receive Covid-19 vaccine

Some 180,000 people with higher risks of coronavirus infection in south China's Guangdong Province have been given Covid-19 vaccine candidates as of Tuesday, the provincial government said

Coronavirus, vaccine, covid, drugs, clinical trials
IANS Guangzhou
1 min read Last Updated : Dec 24 2020 | 8:18 AM IST

Some 180,000 people with higher risks of coronavirus infection in south China's Guangdong Province have been given Covid-19 vaccine candidates as of Tuesday, the provincial government said.

No serious side effects have been reported among the vaccine receivers, said the information office of the local government of Guangdong at a press briefing on Wednesday, Xinhua news agency reported.

The vaccine candidates, still undergoing clinical trials, were made by the China National Biotec Group and Beijing-based Sinovac, said the office.

Guangdong has started a Covid-19 vaccination campaign among groups of people with higher risks of infection. They include medical workers, customs officers, primary-level epidemic prevention workers, overseas returnees, and people working in cross-border cold-chain logistics and isolation centres.

--IANS

int/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusChinaCoronavirus Vaccine

First Published: Dec 24 2020 | 8:08 AM IST

Next Story